Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, January 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 3 news outlets
twitter: 3 X users
patent: 12 patents

facebook: 1 Facebook page
reddit: 2 Redditors

Readers on

mendeley: 53 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 12 patents that reference this research output.

Compositions for use in lysis of selective cancer cells

Grant US-12239720-B2

United States of America

04 Mar 2025

HDM2 ANTIBODY FOR USE IN TREATING CANCER

Application EP-3927362-A4

European Patent Office

23 Nov 2022

Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer

Grant US-11407840-B2

United States of America

09 Aug 2022

COMPOSITIONS FOR USE IN LYSIS OF SELECTIVE CANCER CELLS

Application EP-3773660-A1

European Patent Office

17 Feb 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.